Lenz Therapeutics, Inc. — Form D

Lenz Therapeutics, Inc. of DEL MAR, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-06-30. The offering totals $3.4M, of which $3.4M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
GERALD HORNExecutive OfficerCORONADO, CA
Mark LesterExecutive OfficerTucson, AZ
James McCollumExecutive OfficerDel Mar, CA
Zach ScheinerDirectorBoston, MA
CHRIS DIMITROPOULOSDirectorSAN DIEGO, CA
Clare OzawaDirectorSouth San Francisco, CA
Evert SchimmelpenninkDirectorBryan, TX
Evert SchimmelpenninkExecutive OfficerBryan, TX
James McCollumDirectorDel Mar, CA
Stefan LarsonDirectorDel Mar, CA
Frederic GuerardDirectorDedham, MA
Fred GuerardDirectorDel Mar, CA
Mark W LesterDirectorWellesley, MA
Mark W LesterExecutive OfficerWellesley, MA
Gerald W HornDirectorDeerfield, IL
Gerald W HornExecutive OfficerDeerfield, IL
James W McCollumDirectorCoronado, CA
James W McCollumExecutive OfficerCoronado, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2023-03-10D$83.5M$83.5M
2022-11-22D/A$49.0M$49.0M
2020-11-09D$68.3M$1.8M
2020-09-14D$250K$250K

More